Manhattan Drug Company, Inc.: due-diligence report
Public-record summary and buyer worksheet. Records can be incomplete; a listing is not product approval, an audit result or a guarantee of suitability. This report updates as source records change. Print a dated copy to retain the version you reviewed.
Share this report: https://certifiedmanufacturers.com/manufacturers/manhattan-drug/due-diligence
Profile last verified: Nov 19, 2026. Report printed / reviewed on: ____________________
Certifications and licences
NSF/ANSI 455-2 GMP for Dietary Supplements
Issuer: NSF. Registry status: active. Checked: Nov 19, 2026.
Reference: Not recorded. Expiry: Not recorded.
Scope: Not recorded here; confirm with the registry and manufacturer.
Registry source: https://info.nsf.org/Certified/455GMP/Listings.asp?Facilities
Manhattan Drug Company, Inc., 201 Route 22 West, Hillside, NJ, 07205, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.
Manhattan Drug Company, Inc., 225 Long Avenue, Hillside, NJ, 07205, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.
FDA inspection history
Dataset date: Oct 28, 2026. Facility records are matched by company and location; confirm that the site is the one in your quote. FDA inspection source.
Aug 14, 2025 — VAI: Voluntary action indicated
Manhattan Drug Co. Inc, Hillside, New Jersey, United States. FEI: 2219579; inspection: 1254518.
Food Composition, Standards, Labeling and Econ
21 CFR 111.70(b): Specifications - components
21 CFR 111.113(b)(2): Quality control - reject; specification not met
21 CFR 111.210: Master manufacturing record - record requirements
21 CFR 111.320(b): Examination, testing; scientifically valid
Jul 22, 2021 — NAI: No action indicated
Manhattan Drug Co. Inc, Hillside, New Jersey, United States. FEI: 2219579; inspection: 1147144.
Food Composition, Standards, Labeling and Econ
Jan 30, 2018 — NAI: No action indicated
Manhattan Drug Co Inc, Hillside, New Jersey, United States. FEI: 1000526771; inspection: 1041062.
Food Composition, Standards, Labeling and Econ
Jan 25, 2018 — NAI: No action indicated
Manhattan Drug Co. Inc, Hillside, New Jersey, United States. FEI: 2219579; inspection: 1041066.
Food Composition, Standards, Labeling and Econ
Feb 10, 2015 — NAI: No action indicated
Manhattan Drug Co Inc, Hillside, New Jersey, United States. FEI: 1000526771; inspection: 913422.
Food Composition, Standards, Labeling and Econ
Jan 29, 2015 — VAI: Voluntary action indicated
Manhattan Drug Co. Inc, Hillside, New Jersey, United States. FEI: 2219579; inspection: 912289.
Food Composition, Standards, Labeling and Econ
Jul 16, 2012 — NAI: No action indicated
Manhattan Drug Co Inc, Hillside, New Jersey, United States. FEI: 1000526771; inspection: 790787.
Food Composition, Standards, Labeling and Econ
Jun 26, 2012 — VAI: Voluntary action indicated
Manhattan Drug Co. Inc, Hillside, New Jersey, United States. FEI: 2219579; inspection: 787770.
Food Composition, Standards, Labeling and Econ
21 CFR 111.110(c): Quality control operations - tests, examinations; results
FDA recalls
Dataset date: Nov 19, 2026. Recall matches use company names and may concern a different product or facility.
No matched recall events in the imported dataset. This is not proof of a recall-free history.
Company website claims — not registry verified
Last website check: Oct 16, 2026.
“We can assist our customers with formulating products or use your current formula.”
Last seen Oct 16, 2026. https://manhattandrug.com/
“Our packaging department has six bottle packaging lines for tablets and capsules.”
Last seen Oct 16, 2026. https://manhattandrug.com/
Evidence to request from the manufacturer
Public records cannot answer these questions. Mark each item after reviewing the evidence. Blank means not assessed, not a failed audit. Notes entered here are not saved or included in a shared URL.
Request role-specific training records and the named quality contact.
21 CFR 111.12Request a site walkthrough, sanitation controls and equipment maintenance records (also §111.25).
21 CFR 111.20Request written identity, purity, strength, composition and contaminant specifications for your product.
21 CFR 111.70Ask how each dietary ingredient is identified and how suppliers and certificates of analysis are qualified.
21 CFR 111.75Request quality control procedures, release authority and handling of deviations and rejected batches.
21 CFR 111.105Request the approved product-specific master manufacturing record and change-control process.
21 CFR 111.205Review a completed batch record with traceability to components, processing and release.
21 CFR 111.255Request scientifically valid test methods, sampling plans and laboratory controls for your specifications.
21 CFR 111.315Request procedures that prevent label mix-ups and control packaging and label reconciliation.
21 CFR 111.403Ask how storage conditions protect identity, purity, strength and composition during holding and distribution.
21 CFR 111.453Request complaint review and investigation procedures; discuss returned-product controls under §111.503.
21 CFR 111.553Confirm retention and access to records supporting your batches.
21 CFR 111.605